| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd664c8c233d11674ef0f3782455806f |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 |
| filingDate |
2007-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aec6cb430c93c3bd0e7269582ff90f09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa5b390b14f1d6886a45f8f33f6bf63d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4585743d29f4504147a2f9aab754dbc9 |
| publicationDate |
2009-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2367429-C2 |
| titleOfInvention |
Psoriasis therapy |
| abstract |
FIELD: medicine. n SUBSTANCE: invention refers to medicine and can be used for treatment of psoriasis patients. Simvastatin monotherapy is offered therefor. Said therapy is administered during 2 months. Simvastatin is introduced in a dose 40 mg/days. n EFFECT: therapy ensures effective disease treatment with using one medicine. n 2 ex, 1 tbl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11534490-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10583190-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2472541-C1 |
| priorityDate |
2007-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |